Cognitive-behavior therapy for obsessive-compulsive disorder: A systematic review of the last decade;Terapias de base cognitivo-comportamental do transtorno obsessivo-compulsivo: Revisão sistemática da última década

Revista Brasileira de Psiquiatria

Volumn 29, Issue 3, 2007, Pages 262-270

  Prazeres, Angélica Marques ^a   De Souza, Wanderson Fernandes ^a   Fontenelle, Leonardo F ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Behavior therapy; Cognitive therapy; Obsessive compulsive disorder; Randomized controlled trials; Review literature

Indexed keywords

CLOMIPRAMINE; FLUVOXAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

BEHAVIOR THERAPY; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG EFFICACY; FOLLOW UP; GROUP THERAPY; HUMAN; MENTAL DISEASE; META ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; REVIEW; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; BIBLIOGRAPHIC DATABASE; COMPUTER ASSISTED THERAPY; EVIDENCE BASED MEDICINE; METHODOLOGY; PSYCHOLOGICAL RATING SCALE; STATISTICS;

COGNITIVE THERAPY; DATABASES, BIBLIOGRAPHIC; DESENSITIZATION, PSYCHOLOGIC; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; META-ANALYSIS AS TOPIC; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, GROUP; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; THERAPY, COMPUTER-ASSISTED;

EID: 34748893148     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462006005000046     Document Type: Review

References (56)

1. Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):327-37.
2. Abramowitz JS, Whiteside SP, Deacon BJ. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a metaanalysis. Behav Therapy. 2005;36(1):55-63.
3. Huppert JD, Schultz LT, Foa EB, Barlow DH, Davidson JR, Gorman JM, Shear MK, Simpson HB, Woods SW. Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. Am J Psychiatry. 2004;161(8):1485-7.
4. March JS, Mulle K. OCD in children and adolescents: a cognitive-behavioral treatment manual. New York: The Guilford Press; 1998.
5. Marks I. Behaviour therapy for obsessive-compulsive disorder: a decade of progress. Can J Psychiatry. 1997;42(10):1021-7.
6. Volpato Cordioli A, Heldt E, Braga Bochi D, Margis R, Basso de Sousa M, Fonseca Tonello J, Gus Manfro G, Kapczinski F. Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial. Psychother Psychosom. 2003;72(4):211-6.
7. Beck AT. Cognitive therapy and the emotional disorder. New York: International Universities Press; 1976.
8. Beck AT, Emery G, Greenberg R. Anxiety disorders and phobias. A cognitive perspective. New York: Basic Books; 1985.
9. Salkovskis PM. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav Res Ther. 1985;23(5):571-83.
10. Salkovskis PM, Kirk J. Obsessional disorders. In: Hawton K, Salkovskis PM, Kirk J, Clark D, editors. Cognitive behaviour therapy for psychiatric problems. A practical guide. Oxford: Oxford University Press; 1989. p. 128-68.
11. Marks IM. Fears, phobias and rituals. New York: Oxford University Press; 1987.
12. Lindsay M, Crino R, Andrews G. Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry. 1997;171:135-9.
13. de Araujo LA, Ito LM, Marks IM, Deale A. Does imagined exposure to the consequences of not ritualising enhance live exposure for OCD? A controlled study. I. Main outcome. Br J Psychiatry. 1995;167(1):65-70.
14. Ito LM, Marks IM, de Araujo LA, Hemsley D. Does imagined exposure to the consequences of not ritualising enhance live exposure for OCD? A controlled study. II. Effect on behavioral versus subjective concordance of improvement. Br J Psychiatry. 1995;167(1):71-5.
15. Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM, Clary CM. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry. 2002;63(2):138-45.
16. Lovell K, Cox D, Haddock G, Jones C, Raines D, Garvey R, Roberts C, Hadley S. Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial. BMJ. 2006;333(7574):883-7.
17. O'Connor KP, Aardema F, Bouthillier D, Fournier S, Guay S, Robillard S, Pelissier MC, Landry P, Todorov C, Tremblay M, Pitre D. Evaluation of an inference-based approach to treating obsessive-compulsive disorder. Cogn Behav Ther. 2005;34(3):148-63.
18. van Oppen P, de Haan E, van Balkom AJ, Spinhoven P, Hoogduin K, van Dyck R. Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther. 1995;33(4):379-90.
19. Cottraux J, Note I, Yao SN, Lafont S, Note B, Mollard E, Bouvard M, Sauteraud A, Bourgeois M, Dartigues JF. A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive-compulsive disorder. Psychother Psychosom. 2001;70(6):288-97.
20. Whittal ML, Thordarson DS, McLean PD. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention. Behav Res Ther. 2005;43(12):1559-76.
21. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005;162(1):151-61.
22. Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, Petkova E, Kjernisted K, Huppert JD, Franklin ME, Davies SO, Campeas R. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depress Anxiety. 2004;19(4):225-33.
23. Simpson HB, Franklin ME, Cheng J, Foa EB, Liebowitz MR. Standard criteria for relapse are needed in obsessive-compulsive disorder. Depress Anxiety. 2005;21(1):1-8.
24. Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(2):269-76.
25. Tenneij NH, van Megen HJ, Denys DA, Westenberg HG. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry. 2005;66(9):1169-75.
26. Hohagen F, Winkelmann G, Rasche-Ruchle H, Hand I, Konig A, Munchau N, Hiss H, Geiger-Kabisch C, Kappler C, Schramm P, Rey E, Aldenhoff J, Berger M. Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. Br J Psychiatry Suppl. 1998;(35):71-8.
27. van Balkom AJ, de Haan E, van Oppen P, Spinhoven P, Hoogduin KA, van Dyck R. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis. 1998;186(8):492-9.
28. Nakatani E, Nakagawa A, Nakao T, Yoshizato C, Nabeyama M, Kudo A, Isomura K, Kato N, Yoshioka K, Kawamoto M. A randomized controlled trial of Japanese patients with obsessive-compulsive disorder - effectiveness of behavior therapy and fluvoxamine. Psychother Psychosom. 2005;74(5):269-76.
29. Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(7):1133-9.
30. O'Connor KP, Aardema F, Robillard S, Guay S, Pelissier MC, Todorov C, Borgeat F, Leblanc V, Grenier S, Doucet P. Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatr.Scand. 2006;113(5):408-19.
31. Freeston MH, Ladouceur R, Gagnon F, Thibodeau N, Rheaume J, Letarte H, Bujold A. Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol. 1997;65(3):405-13.
32. de Araujo LA, Ito LM, Marks IM. Early compliance and other factors predicting outcome of exposure for obsessive-compulsive disorder. Br J Psychiatry. 1996;169(6):747-52.
33. Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom. 2002;71(5):255-62.
34. de Haan E, van Oppen P, van Balkom AJ, Spinhoven P, Hoogduin KA, van Dyck R. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatr Scand. 1997;96(5):354-61.
35. Dreessen L, Hoekstra R, Arntz A. Personality disorders do not influence the results of cognitive and behavior therapy for obsessive compulsive disorder. J Anxiety Disord. 1997;11(5):503-21.
36. Vogel PA, Hansen B, Stiles TC, Gotestam KG. Treatment motivation, treatment expectancy, and helping alliance as predictors of outcome in cognitive behavioral treatment of OCD. J Behav Ther Exp Psychiatry. 2006;37(3):247-55.
37. Neziroglu F, Yaryura-Tobias JA, Walz J, McKay D. The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2000;10(4):295-306.
38. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969-76.
39. Asbahr FR, Castillo AR, Ito LM, Latorre MR, Moreira MN, Lotufo-Neto F. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(11):1128-36.
40. Barrett P, Healy-Farrell L, March JS. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(1):46-62.
41. S imons M, Schneider S, Herpertz-Dahlmann B. Metacognitive therapy versus exposure and response prevention for pediatric obsessive-compulsive disorder. A case series with randomized allocation. Psychother Psychosom. 2006;75(4):257-64.
42. Althaus D, Zaudig M, Hauke W, Roper G, Buttollo W. [The efficacy of an inpatient group therapy program for obsessive-compulsive disorder in addition to individual cognitive behavioral therapy and medication]. Verhaltenstherapie. 2000;10(1):16-23.
43. McLean PD, Whittal ML, Thordarson DS, Taylor S, Sochting I, Koch WJ, Paterson R, Anderson KW. Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder. J Consult Clin Psychol. 2001;69(2):205-14.
44. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol. 1997 65(1):44-52.
45. Fisher PL, Wells A. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behav Res Ther. 2005;43(12):1543-58.
46. Abramowitz JS. Does cognitive-behavioral therapy cure obsessive-compulsive disorder? A meta-analytic evaluation of clinical significance. Behav Therapy. 1998;29:339-55.
47. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ. Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psychopharmacology (Berl). 1998;136(3):205-16.
48. Ruhmland M, Margraf J. Efficacy of psychological treatments for specific phobia and obsessive compulsive disorder. Verhaltenstherapie. 2001;11(1):14-26.
49. Eddy KT, Dutra L, Bradley R, Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev. 2004;24(8):1011-30.
50. Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? Biol Psychiatry. 2002;52(10):987-97.
51. Abramowitz JS, Whiteside SP, Deacon BJ. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Therapy. 2005;36(1):55-63.
52. Zucker BG, Craske MG, Blackmore MA, Nitz AA. Cognitive behavioral workshop for subclinical obsessions and compulsions. Behav Res Ther. 2006;44(2):289-304.
53. van Oppen P, van Balkom AJ, de Haan E, van Dyck R. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. J Clin Psychiatry. 2005;66(11):1415-22.
54. Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, Fricke S, Peter H. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial. Eur Arch Psychiatry Clin Neurosci. 2005;255(2):121-8 .
55. Gray GE. Psiquiatria baseada em evidências. Porto Alegre: Artmed; 2004.
56. Neziroglu F, Henricksen J, Yayura-Tobias J. Psychoterapy of obsessive-compulsive disorder and spectrum: established facts and advances, 1995-2005. Psychiatr Clin N Am. 2006;29(2):585-604.